FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES Stock

Certificat

DE000MG34UA4

Real-time Bid/Ask 03:34:04 2024-05-23 EDT
7.15 EUR / 7.5 EUR +0.34% Intraday chart for FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES
Current month-30.54%
Date Price Change
24-05-22 7.3 +1.53%
24-05-21 7.19 +2.42%
24-05-20 7.02 -1.27%
24-05-17 7.11 +4.41%
24-05-16 6.81 -1.02%

Delayed Quote Börse Stuttgart

Last update May 22, 2024 at 03:54 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Morgan Stanley
WKN MG34UA
ISINDE000MG34UA4
Date issued 2024-04-26
Strike 121 $
Maturity Unlimited
Parity 3.11 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.69
Lowest since issue 6.68
Spread 0.35
Spread %4.67%

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
96.6 USD
Average target price
107.9 USD
Spread / Average Target
+11.69%
Consensus